# An Extended Access Program (EAP) for Perampanel

> **NCT02307578** · — · NO_LONGER_AVAILABLE · sponsor: **Eisai Inc.**

## Conditions studied

- Primary Generalized Tonic-Clonic or Partial Onset Seizures
- Lennox Gastaut Syndrome

## Interventions

- **DRUG:** Perampanel

## Key facts

- **NCT ID:** NCT02307578
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2025-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02307578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02307578, "An Extended Access Program (EAP) for Perampanel". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02307578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*